SMR

NuScale Power Redeems Warrants for $0.01

NuScale Power Corporation (NYSE: SMR) has announced the redemption of its outstanding warrants to purchase shares of the company's Class A Common Stock. The redemption date is set for 5:00 p.m. EST on Thursday, December 19, 2024, with a redemption price of $0.01 per warrant. The company has satisfied the condition for redemption, as the last sales price of the Common Stock exceeded $18.00 per share on 20 trading days within the 30-day trading period ending on November 14, 2024.

Warrant holders have the option to exercise their warrants to purchase shares of Common Stock until immediately before 5:00 p.m. EST on the Redemption Date. They can do so by following the procedures outlined in the Notice of Redemption and the Election to Exercise form included with the notice. Warrant holders who fail to exercise their warrants before the Redemption Date will receive $0.01 per warrant.

It's important to note that any outstanding warrants that remain unexercised at 5:00 p.m. EST on the Redemption Date will be void and no longer exercisable, except to receive the Redemption Price or as otherwise described in the Notice of Redemption.

NuScale Power Corporation, founded in 2007, is the industry-leading provider of proprietary and innovative advanced small modular reactor (SMR) nuclear technology. The company's groundbreaking SMR technology is powered by the NuScale Power Module™, a small, safe, pressurized water reactor that can each generate 77 megawatts of electricity (MWe) or 250 megawatts thermal (gross). NuScale is the first and only SMR to have its design certified by the U.S. Nuclear Regulatory Commission.

For more information on the redemption of warrants and NuScale Power Corporation, questions may be directed to Continental Stock Transfer & Trust Company. Today the company's shares have moved -0.8% to a price of $27.04. For the full picture, make sure to review NuScale Power's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS